BJ

Baiju John Thomas

Director DIN 03315574
DIN 03315574 First appointment Aug 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Baiju John Thomas

Data last updated:

Baiju John Thomas was a Director at Optis Healthcare Private Limited (from 2011) and Director at Optis Eye Hospitals Private Limited (from 2012).

DIN 03315574
First Appointment 02 Aug 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Optis Healthcare Private Limited U85110KA2011PTC058394
Director02 Aug 20112011Strike Off
Optis Eye Hospitals Private Limited U85100KA2011PTC059569
Director21 Jun 20122011Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Optis Healthcare Private Limited
Optis Eye Hospitals Private Limited
Premium access

Shareholding and investment profile for Baiju John Thomas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Baiju John Thomas

Baiju John Thomas was first appointed on 02 Aug 2011 as Director at Optis Healthcare Private Limited. The most recent appointment on record is 21 Jun 2012 at Optis Eye Hospitals Private Limited.

Baiju John Thomas held 2 earlier board appointments: Optis Healthcare Private Limited (Director, from 02 Aug 2011); Optis Eye Hospitals Private Limited (Director, from 21 Jun 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available